Jaguar Health

JAGXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$4.665 M

$0.95 +1.14%

Close of 7 Aug 2026

Revenue

$11.5M

#3139 by revenue

Earnings

-$54.0K

Loss-making

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#470Ernexa TherapeuticsERNA$4.91M
#471Silo PharmaSILO$4.68M
#472Jaguar HealthJAGX$4.67M
#473Galmed PharmaceuticalsGLMD$4.63M
#474Mustang BioMBIO$4.55M

Where these numbers come from

Share counts and financials for Jaguar Health are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.